Analysis of the Zidovudine Resistance Mutations T215Y, M41L, and L210W in HIV-1 Reverse Transcriptase

Antimicrobial Agents and Chemotherapy
Paul L BoyerStephen H Hughes

Abstract

Although anti-human immunodeficiency virus type 1 (HIV-1) therapies have become more sophisticated and more effective, drug resistance continues to be a major problem. Zidovudine (azidothymidine; AZT) was the first nucleoside reverse transcriptase (RT) inhibitor (NRTI) approved for the treatment of HIV-1 infections and is still being used, particularly in the developing world. This drug targets the conversion of single-stranded RNA to double-stranded DNA by HIV-1 RT. However, resistance to the drug quickly appeared both in viruses replicating in cells in culture and in patients undergoing AZT monotherapy. The primary resistance pathway selects for mutations of T215 that change the threonine to either a tyrosine or a phenylalanine (T215Y/F); this resistance pathway involves an ATP-dependent excision mechanism. The pseudo-sugar ring of AZT lacks a 3' OH; RT incorporates AZT monophosphate (AZTMP), which blocks the end of the viral DNA primer. AZT-resistant forms of HIV-1 RT use ATP in an excision reaction to unblock the 3' end of the primer strand, allowing its extension by RT. The T215Y AZT resistance mutation is often accompanied by two other mutations, M41L and L210W. In this study, the roles of these mutations, in combination ...Continue Reading

References

Mar 1, 1992·Proceedings of the National Academy of Sciences of the United States of America·P KellamB A Larder
Aug 5, 1998·Proceedings of the National Academy of Sciences of the United States of America·J RenD K Stammers
Feb 18, 2006·PLoS Pathogens·Paul L BoyerStephen H Hughes
Nov 22, 2008·Journal of Molecular Biology·Stefan G SarafianosEddy Arnold
Sep 21, 2010·Nature Structural & Molecular Biology·Xiongying TuEddy Arnold
Feb 3, 2012·Journal of the American Chemical Society·Seema MittalCelia A Schiffer
Oct 3, 2012·Cold Spring Harbor Perspectives in Medicine·Wei-Shau Hu, Stephen H Hughes
Apr 23, 2013·Current Opinion in Virology·Kalyan Das, Eddy Arnold
Apr 23, 2013·Current Opinion in Virology·Kalyan Das, Eddy Arnold
Jun 25, 2015·Microbiology Spectrum·Stephen H Hughes

❮ Previous
Next ❯

Citations

Aug 10, 2021·PLoS Pathogens·Anna ZhukovaVivian Kouri

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.

CRISPR Screens in Drug Resistance

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of CRISPR-Cas system in high-throughput genome-wide screens to identify genes that may confer drug resistance.